All Stories

  1. Specific Binding Peptides from Rv3632: A Strategy for Blocking Mycobacterium tuberculosis Entry to Target Cells?
  2. Experimental models used in evaluating anti-tuberculosis vaccines: the latest advances in the field
  3. Towards designing a synthetic antituberculosis vaccine: The Rv3587c peptide inhibits mycobacterial entry to host cells
  4. Quantifying intracellular Mycobacterium tuberculosis : An essential issue for in vitro assays
  5. Mycobacterium tuberculosis H37Rv LpqG Protein Peptides Can Inhibit Mycobacterial Entry through Specific Interactions
  6. Identifying and characterising PPE7 (Rv0354c) high activity binding peptides and their role in inhibiting cell invasion
  7. Mycobacterium tuberculosis PE9 protein has high activity binding peptides which inhibit target cell invasion
  8. Cell-Peptide Specific Interaction Can InhibitMycobacterium tuberculosis H37RvInfection
  9. Mce4F Mycobacterium tuberculosis protein peptides can inhibit invasion of human cell lines
  10. Specific Interaction betweenMycobacterium tuberculosisLipoprotein-derived Peptides and Target Cells Inhibits Mycobacterial EntryIn Vitro
  11. Rv1268c protein peptide inhibiting Mycobacterium tuberculosis H37Rv entry to target cells
  12. Functional, biochemical and 3D studies ofMycobacterium tuberculosisprotein peptides for an effective anti-tuberculosis vaccine
  13. Mycobacterium tuberculosis surface protein Rv0227c contains high activity binding peptides which inhibit cell invasion
  14. The role of Mycobacterium tuberculosis Rv3166c protein-derived high-activity binding peptides in inhibiting invasion of human cell lines
  15. Peptides derived from Mycobacterium tuberculosis Rv2301 protein are involved in invasion to human epithelial cells and macrophages
  16. The Mycobacterium tuberculosis membrane protein Rv0180c: Evaluation of peptide sequences implicated in mycobacterial invasion of two human cell lines
  17. Computational Prediction and Experimental Assessment of Secreted/Surface Proteins from Mycobacterium tuberculosis H37Rv
  18. Peptides from the Mycobacterium tuberculosis Rv1980c protein involved in human cell infection: insights into new synthetic subunit vaccine candidates
  19. Mycobacterium tuberculosis Rv0679c protein sequences involved in host-cell infection: Potential TB vaccine candidate antigen
  20. Validating subcellular localization prediction tools with mycobacterial proteins
  21. Peptides derived from the Mycobacterium tuberculosis Rv1490 surface protein implicated in inhibition of epithelial cell entry: Potential vaccine candidates?
  22. Functional characterization of Mycobacterium tuberculosis Rv2969c membrane protein
  23. Characterisation of Plasmodium falciparum RESA-like protein peptides that bind specifically to erythrocytes and inhibit invasion
  24. Plasmodium falciparum merozoite surface protein 6 (MSP-6) derived peptides bind erythrocytes and partially inhibit parasite invasion
  25. Plasmodium falciparum TryThrA antigen synthetic peptides block in vitro merozoite invasion to erythrocytes
  26. Identifying putativeMycobacterium tuberculosisRv2004c protein sequences that bind specifically to U937 macrophages and A549 epithelial cells
  27. Mycobacterium tuberculosisRv2536 protein implicated in specific binding to human cell lines
  28. Peptides from the Plasmodium falciparum STEVOR putative protein bind with high affinity to normal human red blood cells
  29. IdentifyingPlasmodium falciparummerozoite surface antigen 3 (MSP3) protein peptides that bind specifically to erythrocytes and inhibit merozoite invasion
  30. Characterising Mycobacterium tuberculosis Rv1510c protein and determining its sequences that specifically bind to two target cell lines
  31. Identifying Plasmodium falciparum merozoite surface protein-10 human erythrocyte specific binding regions
  32. Amino terminal peptides from the Plasmodium falciparum EBA-181/JESEBL protein bind specifically to erythrocytes and inhibit in vitro merozoite invasion
  33. Specific erythrocyte binding capacity and biological activity of Plasmodium falciparum erythrocyte binding ligand 1 (EBL-1)-derived peptides
  34. Identifying Plasmodium falciparum cytoadherence-linked asexual protein 3 (CLAG 3) sequences that specifically bind to C32 cells and erythrocytes
  35. P. falciparum pro-histoaspartic protease (proHAP) protein peptides bind specifically to erythrocytes and inhibit the invasion process in vitro
  36. Mapping the anatomy of a Plasmodium falciparum MSP-1 epitope using pseudopeptide-induced mono- and polyclonal antibodies and CD and NMR conformation analysis
  37. Identifying Plasmodium falciparum EBA-175 homologue sequences that specifically bind to human erythrocytes
  38. Liver stage antigen 3 Plasmodium falciparum peptides specifically interacting with HepG2 cells
  39. Sporozoite and Liver Stage Antigen Plasmodium falciparum peptides bind specifically to human hepatocytes
  40. MAEBL Plasmodium falciparum protein peptides bind specifically to erythrocytes and inhibit in vitro merozoite invasion
  41. Identification of Plasmodium falciparum reticulocyte binding protein RBP-2 homologue a and b (PfRBP-2-Ha and -Hb) sequences that specifically bind to erythrocytes
  42. Specific erythrocyte binding capacity and biological activity of Plasmodium falciparum-derived rhoptry-associated protein 1 peptides
  43. Plasmodium falciparum: red blood cell binding studies using peptides derived from rhoptry-associated protein 2 (RAP2)
  44. Plasmodium falciparum EBA-140 kDa protein peptides that bind to human red blood cells
  45. Erratum to “Peptides of the liver stage antigen-1 (LSA-1) of Plasmodium falciparum bind to human hepatocytes” [Peptides 24 (2003) 647–657]
  46. Human papillomavirus type 16 and 18 L1 protein peptide binding to VERO and HeLa cells inhibits their VLPs binding
  47. Plasmodium falciparum normocyte binding protein (PfNBP-1) peptides bind specifically to human erythrocytes
  48. P. falciparum: merozoite surface protein-8 peptides bind specifically to human erythrocytes
  49. Identification of specific Hep G2 cell binding regions in Plasmodium falciparum sporozoite–threonine–asparagine-rich protein (STARP)
  50. Peptides of the liver stage antigen-1 (LSA-1) of Plasmodium falciparum bind to human hepatocytes
  51. Identification and polymorphism of Plasmodium vivax RBP-1 peptides which bind specifically to reticulocytes
  52. Hepatitis C virus (HCV) E1 and E2 protein regions that specifically bind to HepG2 cells
  53. Plasmodium vivax MSP-1 peptides have high specific binding activity to human reticulocytes
  54. Plasmodium vivax Duffy binding protein peptides specifically bind to reticulocytes
  55. Structure, Immunogenicity, and Protectivity Relationship for the 1585 Malarial Peptide and Its Substitution Analogues
  56. Plasmodium vivax: functional analysis of a highly conserved PvRBP-1 protein region
  57. Plasmodium falciparum : binding studies of peptide derived from the sporozoite surface protein 2 to Hep G2 cells
  58. Plasmodium falciparum circumsporozoite (CS) protein peptides specifically bind to HepG2 cells
  59. Plasmodium falciparum acid basic repeat antigen (ABRA) peptides: erythrocyte binding and biological activity
  60. Two MSA 2 peptides that bind to human red blood cells are relevant to Plasmodium falciparum merozoite invasion
  61. Plasmodium falciparum EBA-175 kDa protein peptides which bind to human red blood cells